Pharma & Healthcare
Global Human Insulin Drugs Market Research Report 2025
- Mar 11, 25
- ID: 29329
- Pages: 86
- Figures: 84
- Views: 16
The global market for Human Insulin Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Insulin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Insulin Drugs.
The Human Insulin Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Insulin Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Insulin Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novo Nordisk
Sanofi
Eli Lilly
Biocon
Pfizer
Wockhardt
Julphar
Exir
Sedico
Segment by Type
Basal or Long-acting Insulins
Bolus or Fast-acting Insulins
Traditional Human Insulins
Combination Insulins
Biosimilar Insulins
Segment by Application
Hospital
Household
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Insulin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Insulin Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Insulin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Insulin Drugs.
The Human Insulin Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Insulin Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Insulin Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novo Nordisk
Sanofi
Eli Lilly
Biocon
Pfizer
Wockhardt
Julphar
Exir
Sedico
Segment by Type
Basal or Long-acting Insulins
Bolus or Fast-acting Insulins
Traditional Human Insulins
Combination Insulins
Biosimilar Insulins
Segment by Application
Hospital
Household
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Insulin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Insulin Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Human Insulin Drugs Market Overview
1.1 Product Definition
1.2 Human Insulin Drugs by Type
1.2.1 Global Human Insulin Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Basal or Long-acting Insulins
1.2.3 Bolus or Fast-acting Insulins
1.2.4 Traditional Human Insulins
1.2.5 Combination Insulins
1.2.6 Biosimilar Insulins
1.3 Human Insulin Drugs by Application
1.3.1 Global Human Insulin Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Household
1.4 Global Human Insulin Drugs Market Size Estimates and Forecasts
1.4.1 Global Human Insulin Drugs Revenue 2020-2031
1.4.2 Global Human Insulin Drugs Sales 2020-2031
1.4.3 Global Human Insulin Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Insulin Drugs Market Competition by Manufacturers
2.1 Global Human Insulin Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Insulin Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Insulin Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Insulin Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Insulin Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Insulin Drugs, Product Type & Application
2.7 Global Key Manufacturers of Human Insulin Drugs, Date of Enter into This Industry
2.8 Global Human Insulin Drugs Market Competitive Situation and Trends
2.8.1 Global Human Insulin Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Insulin Drugs Players Market Share by Revenue
2.8.3 Global Human Insulin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Insulin Drugs Market Scenario by Region
3.1 Global Human Insulin Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Insulin Drugs Sales by Region: 2020-2031
3.2.1 Global Human Insulin Drugs Sales by Region: 2020-2025
3.2.2 Global Human Insulin Drugs Sales by Region: 2026-2031
3.3 Global Human Insulin Drugs Revenue by Region: 2020-2031
3.3.1 Global Human Insulin Drugs Revenue by Region: 2020-2025
3.3.2 Global Human Insulin Drugs Revenue by Region: 2026-2031
3.4 North America Human Insulin Drugs Market Facts & Figures by Country
3.4.1 North America Human Insulin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Insulin Drugs Sales by Country (2020-2031)
3.4.3 North America Human Insulin Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Insulin Drugs Market Facts & Figures by Country
3.5.1 Europe Human Insulin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Insulin Drugs Sales by Country (2020-2031)
3.5.3 Europe Human Insulin Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Insulin Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Human Insulin Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Insulin Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Insulin Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Insulin Drugs Market Facts & Figures by Country
3.7.1 Latin America Human Insulin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Insulin Drugs Sales by Country (2020-2031)
3.7.3 Latin America Human Insulin Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Insulin Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Insulin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Insulin Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Insulin Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Insulin Drugs Sales by Type (2020-2031)
4.1.1 Global Human Insulin Drugs Sales by Type (2020-2025)
4.1.2 Global Human Insulin Drugs Sales by Type (2026-2031)
4.1.3 Global Human Insulin Drugs Sales Market Share by Type (2020-2031)
4.2 Global Human Insulin Drugs Revenue by Type (2020-2031)
4.2.1 Global Human Insulin Drugs Revenue by Type (2020-2025)
4.2.2 Global Human Insulin Drugs Revenue by Type (2026-2031)
4.2.3 Global Human Insulin Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Human Insulin Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Insulin Drugs Sales by Application (2020-2031)
5.1.1 Global Human Insulin Drugs Sales by Application (2020-2025)
5.1.2 Global Human Insulin Drugs Sales by Application (2026-2031)
5.1.3 Global Human Insulin Drugs Sales Market Share by Application (2020-2031)
5.2 Global Human Insulin Drugs Revenue by Application (2020-2031)
5.2.1 Global Human Insulin Drugs Revenue by Application (2020-2025)
5.2.2 Global Human Insulin Drugs Revenue by Application (2026-2031)
5.2.3 Global Human Insulin Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Human Insulin Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Human Insulin Drugs Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Human Insulin Drugs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Company Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly Human Insulin Drugs Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Biocon
6.4.1 Biocon Company Information
6.4.2 Biocon Description and Business Overview
6.4.3 Biocon Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biocon Human Insulin Drugs Product Portfolio
6.4.5 Biocon Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Human Insulin Drugs Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Wockhardt
6.6.1 Wockhardt Company Information
6.6.2 Wockhardt Description and Business Overview
6.6.3 Wockhardt Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Wockhardt Human Insulin Drugs Product Portfolio
6.6.5 Wockhardt Recent Developments/Updates
6.7 Julphar
6.7.1 Julphar Company Information
6.7.2 Julphar Description and Business Overview
6.7.3 Julphar Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Julphar Human Insulin Drugs Product Portfolio
6.7.5 Julphar Recent Developments/Updates
6.8 Exir
6.8.1 Exir Company Information
6.8.2 Exir Description and Business Overview
6.8.3 Exir Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Exir Human Insulin Drugs Product Portfolio
6.8.5 Exir Recent Developments/Updates
6.9 Sedico
6.9.1 Sedico Company Information
6.9.2 Sedico Description and Business Overview
6.9.3 Sedico Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sedico Human Insulin Drugs Product Portfolio
6.9.5 Sedico Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Insulin Drugs Industry Chain Analysis
7.2 Human Insulin Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Insulin Drugs Production Mode & Process Analysis
7.4 Human Insulin Drugs Sales and Marketing
7.4.1 Human Insulin Drugs Sales Channels
7.4.2 Human Insulin Drugs Distributors
7.5 Human Insulin Drugs Customer Analysis
8 Human Insulin Drugs Market Dynamics
8.1 Human Insulin Drugs Industry Trends
8.2 Human Insulin Drugs Market Drivers
8.3 Human Insulin Drugs Market Challenges
8.4 Human Insulin Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Human Insulin Drugs by Type
1.2.1 Global Human Insulin Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Basal or Long-acting Insulins
1.2.3 Bolus or Fast-acting Insulins
1.2.4 Traditional Human Insulins
1.2.5 Combination Insulins
1.2.6 Biosimilar Insulins
1.3 Human Insulin Drugs by Application
1.3.1 Global Human Insulin Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Household
1.4 Global Human Insulin Drugs Market Size Estimates and Forecasts
1.4.1 Global Human Insulin Drugs Revenue 2020-2031
1.4.2 Global Human Insulin Drugs Sales 2020-2031
1.4.3 Global Human Insulin Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Insulin Drugs Market Competition by Manufacturers
2.1 Global Human Insulin Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Insulin Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Insulin Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Insulin Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Insulin Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Insulin Drugs, Product Type & Application
2.7 Global Key Manufacturers of Human Insulin Drugs, Date of Enter into This Industry
2.8 Global Human Insulin Drugs Market Competitive Situation and Trends
2.8.1 Global Human Insulin Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Insulin Drugs Players Market Share by Revenue
2.8.3 Global Human Insulin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Insulin Drugs Market Scenario by Region
3.1 Global Human Insulin Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Insulin Drugs Sales by Region: 2020-2031
3.2.1 Global Human Insulin Drugs Sales by Region: 2020-2025
3.2.2 Global Human Insulin Drugs Sales by Region: 2026-2031
3.3 Global Human Insulin Drugs Revenue by Region: 2020-2031
3.3.1 Global Human Insulin Drugs Revenue by Region: 2020-2025
3.3.2 Global Human Insulin Drugs Revenue by Region: 2026-2031
3.4 North America Human Insulin Drugs Market Facts & Figures by Country
3.4.1 North America Human Insulin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Insulin Drugs Sales by Country (2020-2031)
3.4.3 North America Human Insulin Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Insulin Drugs Market Facts & Figures by Country
3.5.1 Europe Human Insulin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Insulin Drugs Sales by Country (2020-2031)
3.5.3 Europe Human Insulin Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Insulin Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Human Insulin Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Insulin Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Insulin Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Insulin Drugs Market Facts & Figures by Country
3.7.1 Latin America Human Insulin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Insulin Drugs Sales by Country (2020-2031)
3.7.3 Latin America Human Insulin Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Insulin Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Insulin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Insulin Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Insulin Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Insulin Drugs Sales by Type (2020-2031)
4.1.1 Global Human Insulin Drugs Sales by Type (2020-2025)
4.1.2 Global Human Insulin Drugs Sales by Type (2026-2031)
4.1.3 Global Human Insulin Drugs Sales Market Share by Type (2020-2031)
4.2 Global Human Insulin Drugs Revenue by Type (2020-2031)
4.2.1 Global Human Insulin Drugs Revenue by Type (2020-2025)
4.2.2 Global Human Insulin Drugs Revenue by Type (2026-2031)
4.2.3 Global Human Insulin Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Human Insulin Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Insulin Drugs Sales by Application (2020-2031)
5.1.1 Global Human Insulin Drugs Sales by Application (2020-2025)
5.1.2 Global Human Insulin Drugs Sales by Application (2026-2031)
5.1.3 Global Human Insulin Drugs Sales Market Share by Application (2020-2031)
5.2 Global Human Insulin Drugs Revenue by Application (2020-2031)
5.2.1 Global Human Insulin Drugs Revenue by Application (2020-2025)
5.2.2 Global Human Insulin Drugs Revenue by Application (2026-2031)
5.2.3 Global Human Insulin Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Human Insulin Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Human Insulin Drugs Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Human Insulin Drugs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Company Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly Human Insulin Drugs Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Biocon
6.4.1 Biocon Company Information
6.4.2 Biocon Description and Business Overview
6.4.3 Biocon Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biocon Human Insulin Drugs Product Portfolio
6.4.5 Biocon Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Human Insulin Drugs Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Wockhardt
6.6.1 Wockhardt Company Information
6.6.2 Wockhardt Description and Business Overview
6.6.3 Wockhardt Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Wockhardt Human Insulin Drugs Product Portfolio
6.6.5 Wockhardt Recent Developments/Updates
6.7 Julphar
6.7.1 Julphar Company Information
6.7.2 Julphar Description and Business Overview
6.7.3 Julphar Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Julphar Human Insulin Drugs Product Portfolio
6.7.5 Julphar Recent Developments/Updates
6.8 Exir
6.8.1 Exir Company Information
6.8.2 Exir Description and Business Overview
6.8.3 Exir Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Exir Human Insulin Drugs Product Portfolio
6.8.5 Exir Recent Developments/Updates
6.9 Sedico
6.9.1 Sedico Company Information
6.9.2 Sedico Description and Business Overview
6.9.3 Sedico Human Insulin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sedico Human Insulin Drugs Product Portfolio
6.9.5 Sedico Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Insulin Drugs Industry Chain Analysis
7.2 Human Insulin Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Insulin Drugs Production Mode & Process Analysis
7.4 Human Insulin Drugs Sales and Marketing
7.4.1 Human Insulin Drugs Sales Channels
7.4.2 Human Insulin Drugs Distributors
7.5 Human Insulin Drugs Customer Analysis
8 Human Insulin Drugs Market Dynamics
8.1 Human Insulin Drugs Industry Trends
8.2 Human Insulin Drugs Market Drivers
8.3 Human Insulin Drugs Market Challenges
8.4 Human Insulin Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Human Insulin Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Human Insulin Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Human Insulin Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human Insulin Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Human Insulin Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human Insulin Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human Insulin Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human Insulin Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human Insulin Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Insulin Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Insulin Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Human Insulin Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Insulin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Insulin Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human Insulin Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Human Insulin Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Human Insulin Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Human Insulin Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Human Insulin Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human Insulin Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Human Insulin Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human Insulin Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Human Insulin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human Insulin Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Human Insulin Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Human Insulin Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human Insulin Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human Insulin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human Insulin Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Human Insulin Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Human Insulin Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human Insulin Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human Insulin Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human Insulin Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Human Insulin Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Human Insulin Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human Insulin Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Insulin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human Insulin Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Human Insulin Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Human Insulin Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human Insulin Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Human Insulin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Human Insulin Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Human Insulin Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Human Insulin Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Human Insulin Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human Insulin Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Human Insulin Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Human Insulin Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Human Insulin Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Human Insulin Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human Insulin Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human Insulin Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Human Insulin Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Human Insulin Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Human Insulin Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Human Insulin Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Human Insulin Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Human Insulin Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Human Insulin Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Human Insulin Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human Insulin Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human Insulin Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Human Insulin Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Human Insulin Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Human Insulin Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novo Nordisk Human Insulin Drugs Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sanofi Human Insulin Drugs Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Eli Lilly Human Insulin Drugs Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Biocon Company Information
Table 86. Biocon Description and Business Overview
Table 87. Biocon Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Biocon Human Insulin Drugs Product
Table 89. Biocon Recent Developments/Updates
Table 90. Pfizer Company Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Pfizer Human Insulin Drugs Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Wockhardt Company Information
Table 96. Wockhardt Description and Business Overview
Table 97. Wockhardt Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Wockhardt Human Insulin Drugs Product
Table 99. Wockhardt Recent Developments/Updates
Table 100. Julphar Company Information
Table 101. Julphar Description and Business Overview
Table 102. Julphar Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Julphar Human Insulin Drugs Product
Table 104. Julphar Recent Developments/Updates
Table 105. Exir Company Information
Table 106. Exir Description and Business Overview
Table 107. Exir Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Exir Human Insulin Drugs Product
Table 109. Exir Recent Developments/Updates
Table 110. Sedico Company Information
Table 111. Sedico Description and Business Overview
Table 112. Sedico Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Sedico Human Insulin Drugs Product
Table 114. Sedico Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Human Insulin Drugs Distributors List
Table 118. Human Insulin Drugs Customers List
Table 119. Human Insulin Drugs Market Trends
Table 120. Human Insulin Drugs Market Drivers
Table 121. Human Insulin Drugs Market Challenges
Table 122. Human Insulin Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Insulin Drugs
Figure 2. Global Human Insulin Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Insulin Drugs Market Share by Type: 2024 & 2031
Figure 4. Basal or Long-acting Insulins Product Picture
Figure 5. Bolus or Fast-acting Insulins Product Picture
Figure 6. Traditional Human Insulins Product Picture
Figure 7. Combination Insulins Product Picture
Figure 8. Biosimilar Insulins Product Picture
Figure 9. Global Human Insulin Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Human Insulin Drugs Market Share by Application: 2024 & 2031
Figure 11. Hospital
Figure 12. Household
Figure 13. Global Human Insulin Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Human Insulin Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Human Insulin Drugs Sales (2020-2031) & (K Units)
Figure 16. Global Human Insulin Drugs Average Price (US$/Unit) & (2020-2031)
Figure 17. Human Insulin Drugs Report Years Considered
Figure 18. Human Insulin Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Human Insulin Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Human Insulin Drugs Players: Market Share by Revenue in Human Insulin Drugs in 2024
Figure 21. Human Insulin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Human Insulin Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Human Insulin Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Human Insulin Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Human Insulin Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Human Insulin Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Human Insulin Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Human Insulin Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Human Insulin Drugs Sales Market Share by Country (2020-2031)
Figure 46. Latin America Human Insulin Drugs Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Human Insulin Drugs Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Human Insulin Drugs Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Human Insulin Drugs by Type (2020-2031)
Figure 56. Global Revenue Market Share of Human Insulin Drugs by Type (2020-2031)
Figure 57. Global Human Insulin Drugs Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Human Insulin Drugs by Application (2020-2031)
Figure 59. Global Revenue Market Share of Human Insulin Drugs by Application (2020-2031)
Figure 60. Global Human Insulin Drugs Price (US$/Unit) by Application (2020-2031)
Figure 61. Human Insulin Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Human Insulin Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Human Insulin Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Human Insulin Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human Insulin Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Human Insulin Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human Insulin Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human Insulin Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human Insulin Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human Insulin Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Insulin Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Insulin Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Human Insulin Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Insulin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Insulin Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human Insulin Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Human Insulin Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Human Insulin Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Human Insulin Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Human Insulin Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human Insulin Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Human Insulin Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human Insulin Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Human Insulin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human Insulin Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Human Insulin Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Human Insulin Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human Insulin Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human Insulin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human Insulin Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Human Insulin Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Human Insulin Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human Insulin Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human Insulin Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human Insulin Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Human Insulin Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Human Insulin Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human Insulin Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Insulin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human Insulin Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Human Insulin Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Human Insulin Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human Insulin Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Human Insulin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Human Insulin Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Human Insulin Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Human Insulin Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Human Insulin Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human Insulin Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Human Insulin Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Human Insulin Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Human Insulin Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Human Insulin Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human Insulin Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human Insulin Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Human Insulin Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Human Insulin Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Human Insulin Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Human Insulin Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Human Insulin Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Human Insulin Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Human Insulin Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Human Insulin Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human Insulin Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human Insulin Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Human Insulin Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Human Insulin Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Human Insulin Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novo Nordisk Human Insulin Drugs Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sanofi Human Insulin Drugs Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Eli Lilly Human Insulin Drugs Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Biocon Company Information
Table 86. Biocon Description and Business Overview
Table 87. Biocon Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Biocon Human Insulin Drugs Product
Table 89. Biocon Recent Developments/Updates
Table 90. Pfizer Company Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Pfizer Human Insulin Drugs Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Wockhardt Company Information
Table 96. Wockhardt Description and Business Overview
Table 97. Wockhardt Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Wockhardt Human Insulin Drugs Product
Table 99. Wockhardt Recent Developments/Updates
Table 100. Julphar Company Information
Table 101. Julphar Description and Business Overview
Table 102. Julphar Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Julphar Human Insulin Drugs Product
Table 104. Julphar Recent Developments/Updates
Table 105. Exir Company Information
Table 106. Exir Description and Business Overview
Table 107. Exir Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Exir Human Insulin Drugs Product
Table 109. Exir Recent Developments/Updates
Table 110. Sedico Company Information
Table 111. Sedico Description and Business Overview
Table 112. Sedico Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Sedico Human Insulin Drugs Product
Table 114. Sedico Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Human Insulin Drugs Distributors List
Table 118. Human Insulin Drugs Customers List
Table 119. Human Insulin Drugs Market Trends
Table 120. Human Insulin Drugs Market Drivers
Table 121. Human Insulin Drugs Market Challenges
Table 122. Human Insulin Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Insulin Drugs
Figure 2. Global Human Insulin Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Insulin Drugs Market Share by Type: 2024 & 2031
Figure 4. Basal or Long-acting Insulins Product Picture
Figure 5. Bolus or Fast-acting Insulins Product Picture
Figure 6. Traditional Human Insulins Product Picture
Figure 7. Combination Insulins Product Picture
Figure 8. Biosimilar Insulins Product Picture
Figure 9. Global Human Insulin Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Human Insulin Drugs Market Share by Application: 2024 & 2031
Figure 11. Hospital
Figure 12. Household
Figure 13. Global Human Insulin Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Human Insulin Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Human Insulin Drugs Sales (2020-2031) & (K Units)
Figure 16. Global Human Insulin Drugs Average Price (US$/Unit) & (2020-2031)
Figure 17. Human Insulin Drugs Report Years Considered
Figure 18. Human Insulin Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Human Insulin Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Human Insulin Drugs Players: Market Share by Revenue in Human Insulin Drugs in 2024
Figure 21. Human Insulin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Human Insulin Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Human Insulin Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Human Insulin Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Human Insulin Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Human Insulin Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Human Insulin Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Human Insulin Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Human Insulin Drugs Sales Market Share by Country (2020-2031)
Figure 46. Latin America Human Insulin Drugs Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Human Insulin Drugs Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Human Insulin Drugs Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Human Insulin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Human Insulin Drugs by Type (2020-2031)
Figure 56. Global Revenue Market Share of Human Insulin Drugs by Type (2020-2031)
Figure 57. Global Human Insulin Drugs Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Human Insulin Drugs by Application (2020-2031)
Figure 59. Global Revenue Market Share of Human Insulin Drugs by Application (2020-2031)
Figure 60. Global Human Insulin Drugs Price (US$/Unit) by Application (2020-2031)
Figure 61. Human Insulin Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232